Swiss Biotech Boom: Life sciences startups dominate top 100 awards

Exciting news for the Swiss biotech frontline! The TOP 100 Start-Up award is hosted by Startup.ch the Swiss start-up platform (through IFJ Institut für Jungunternehmen) in collaboration with the major paper Handelszeitung and PME Magazine, ranking the 100 most promising new start up companies. Of these 100, a whopping 68 of these start-ups are in the life sciences sector.

Here we look at 3 of the Top-10 winners which are Swiss biotechs we found to be most interesting:

(Source Lunophore)

The Abionic Team at the Start-up Awards (Courtesy of IFJ)

ADVERTISEMENT

logo

N°2  Abionic SA from Lausanne is a spin-off of the Swiss Federal Institute of Technology (EPFL). They have developed a nanotechnology based diagnostic tool for medical practitioners which provides patients with a personalised allergy profile.

Source: Abionic

Source: Abionic


Sophia-GeneticsN°5 Sophia Genetics is a medical bioinformatics software which is designed to advice medical clinicians in genetic diagnostics using a bank of patient DNA sequences. Using a series of software modules as a data sharing and storage platform, Sophia Genetics is already implemented into 50+  hospitals and labs across the EU.

Source: Sophia Genetics

Source: Sophia Genetics


Unbenannt631N°10 is Lunaphore who have produced a immunohistochemical technique using its fast fluidic exchange technology, which reduces tumor analysis time down to 5 minutes compared to 2-8  hours of existing tests. Lunaphore also claims their technique reduces lab overall costs of assays from 50-70%.

dfef


Switzerland is already famous for its Biotech industry (Roche, Novartis to name a few). These Biotech startups look to carry the torch as a new generation of Biotech excellence.

Let's Continue The Conversation

Feel free to send us comments about this article to comments@labiotech.eu and/or comment on that article on social media.

We use cookies to give you the best experience and for advertising purposes. By accepting, you support our independent media and it's freely accessible content.